Field Compliance
Screen notes, CRM entries, and interaction summaries for policy and documentation risk.
Governed AI workflows for field, medical, promotional, financial, safety, and enterprise execution.
AI in pharma cannot scale without embedded governance. Improzo adds policy, compliance, safety, and audit guardrails directly into execution workflows.
Compliance and governance teams in pharma are not the last line of defense by choice — they are positioned that way by systems that treat governance as a review step rather than an embedded control. The result is that risk is managed after it has already moved through the workflow.
AI in pharma cannot depend on governance after the fact. Compliance & Governance AI places policy, safety, spend, and audit controls directly inside the workflows where content, documentation, summaries, and actions are created.
Screen notes, CRM entries, and interaction summaries for policy and documentation risk.
Apply governance to medical summaries, scientific content, digests, and engagement outputs.
Detect and route potential safety signals from structured and unstructured inputs.
Monitor KOL, speaker, event, and engagement spend for exceptions and high-risk patterns.
Compliance & Governance AI uses advanced AI to embed policy controls, safety detection, and spend monitoring directly into the workflows where risk originates — so governance moves from reactive review to proactive execution.
Embed compliance, policy, AE/PV, spend, and risk guardrails directly into AI-enabled pharma workflows.
Reviews captured or AI-generated content for compliance-sensitive language and documentation risk.
Applies enterprise rules and governance logic across AI outputs and workflow actions.
Detects and routes potential adverse event or pharmacovigilance mentions from structured and unstructured inputs.
Monitors spend, events, KOL engagement, and commercial activity for risk signals.
Reviews captured or AI-generated content for compliance-sensitive language and documentation risk.
Applies enterprise rules and governance logic across AI outputs and workflow actions.
Detects and routes potential adverse event or pharmacovigilance mentions from structured and unstructured inputs.
Monitors spend, events, KOL engagement, and commercial activity for risk signals.
How life sciences organizations are moving beyond analytics into agentic AI systems that actively execute, optimize, and adapt in real time.
Cofounder and Chief Technology Officer
Executive Director, Technology Management
Director, Sales & Business Development